155 related articles for article (PubMed ID: 22690090)
1. Changes of gene expression after bone marrow cell transfusion in rats with monocrotaline-induced pulmonary hypertension.
Kim KC; Lee HR; Kim SJ; Cho MS; Hong YM
J Korean Med Sci; 2012 Jun; 27(6):605-13. PubMed ID: 22690090
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.
Lee H; Lee JC; Kwon JH; Kim KC; Cho MS; Yang YS; Oh W; Choi SJ; Seo ES; Lee SJ; Wang TJ; Hong YM
J Korean Med Sci; 2015 May; 30(5):576-85. PubMed ID: 25931788
[TBL] [Abstract][Full Text] [Related]
3. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
[TBL] [Abstract][Full Text] [Related]
4. Effect of small hairpin RNA targeting endothelin-converting enzyme-1 in monocrotaline-induced pulmonary hypertensive rats.
Son JS; Kim KC; Kim BK; Cho MS; Hong YM
J Korean Med Sci; 2012 Dec; 27(12):1507-16. PubMed ID: 23255850
[TBL] [Abstract][Full Text] [Related]
5. Benefit of combined therapy with nicorandil and colchicine in preventing monocrotaline-induced rat pulmonary arterial hypertension.
Lee FY; Lu HI; Zhen YY; Leu S; Chen YL; Tsai TH; Chung SY; Chua S; Sheu JJ; Hsu SY; Chang HW; Sun CK; Yip HK
Eur J Pharm Sci; 2013 Nov; 50(3-4):372-84. PubMed ID: 23954457
[TBL] [Abstract][Full Text] [Related]
6. Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice.
Aliotta JM; Pereira M; Amaral A; Sorokina A; Igbinoba Z; Hasslinger A; El-Bizri R; Rounds SI; Quesenberry PJ; Klinger JR
Cardiovasc Res; 2013 Dec; 100(3):354-62. PubMed ID: 23867631
[TBL] [Abstract][Full Text] [Related]
7. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
Yip HK; Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Fu M
Crit Care Med; 2008 Mar; 36(3):873-80. PubMed ID: 18431275
[TBL] [Abstract][Full Text] [Related]
8. Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats.
Sun CK; Lee FY; Sheu JJ; Yuen CM; Chua S; Chung SY; Chai HT; Chen YT; Kao YH; Chang LT; Yip HK
J Pharmacol Exp Ther; 2009 Sep; 330(3):718-26. PubMed ID: 19528354
[TBL] [Abstract][Full Text] [Related]
9. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
10. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
[TBL] [Abstract][Full Text] [Related]
11. Pinocembrin ex vivo preconditioning improves the therapeutic efficacy of endothelial progenitor cells in monocrotaline-induced pulmonary hypertension in rats.
Ahmed LA; Rizk SM; El-Maraghy SA
Biochem Pharmacol; 2017 Aug; 138():193-204. PubMed ID: 28450224
[TBL] [Abstract][Full Text] [Related]
12. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
13. 4-Chloro-DL-phenylalanine protects against monocrotaline‑induced pulmonary vascular remodeling and lung inflammation.
Bai Y; Wang HM; Liu M; Wang Y; Lian GC; Zhang XH; Kang J; Wang HL
Int J Mol Med; 2014 Feb; 33(2):373-82. PubMed ID: 24337018
[TBL] [Abstract][Full Text] [Related]
14. [Early treatment with hepatocyte growth factor improves pulmonary artery and right ventricular remodeling in rats with pulmonary artery hypertension by modulating cytokines expression].
Wang X; Wang Y; Rong S; Ma H
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):427-32. PubMed ID: 25200042
[TBL] [Abstract][Full Text] [Related]
15. Cilostazol therapy attenuates monocrotaline-induced pulmonary arterial hypertension in rat model.
Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Yip HK
Circ J; 2008 May; 72(5):825-31. PubMed ID: 18441466
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.
Voelkel NF; Tuder RM; Bridges J; Arend WP
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):664-75. PubMed ID: 7946395
[TBL] [Abstract][Full Text] [Related]
18. Adipose-derived regenerative cell therapy inhibits the progression of monocrotaline-induced pulmonary hypertension in rats.
Eguchi M; Ikeda S; Kusumoto S; Sato D; Koide Y; Kawano H; Maemura K
Life Sci; 2014 Nov; 118(2):306-12. PubMed ID: 24853385
[TBL] [Abstract][Full Text] [Related]
19. Changes of pulmonary pathology and gene expressions after simvastatin treatment in the monocrotaline-induced pulmonary hypertension rat model.
Lee YH; Kim KC; Cho MS; Hong YM
Korean Circ J; 2011 Sep; 41(9):518-27. PubMed ID: 22022327
[TBL] [Abstract][Full Text] [Related]
20. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
Mathew R; Zeballos GA; Tun H; Gewitz MH
Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
